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Among inherited retinal dystrophies, autosomal recessive retinitis pigmentosa (arRP) is the 
most genetically heterogenous condition with 32 genes currently known that account for ~60 
% of patients. Molecular diagnosis thus requires the tedious systematic sequencing of 506 
exons. To rapidly identify the causative mutations, we devised a strategy that combines gene 
mapping and phenotype assessment in small non consanguineous families. Two unrelated 
sibships with arRP had whole-genome scan using SNP microchips. Chromosomal regions 
were selected by calculating a score based on SNP coverage and genotype identity of affected 
patients. Candidate genes from the regions with the highest scores were then selected based 
on phenotype concordance of affected patients with previously described phenotype for each 
candidate gene. For families RP127 and RP1459, 33 and 40 chromosomal regions showed 
possible linkage, respectively. By comparing the scores with the phenotypes, we ended with 
one best candidate gene for each family, namely TULP1 and C2ORF71 for RP127 and 
RP1459, respectively. We found that RP127 patients were compound heterozygous for 2 
novel TULP1 mutations, p.Arg311Gln and p.Arg342Gln, and that RP1459 patients were 
compound heterozygous for 2 novel C2ORF71 mutations, p.Leu777PhefsX34 and 
p.Leu777AsnfsX28. Phenotype assessment showed that TULP1 patients had severe early 
onset arRP and that C2ORF71 patients had a cone rod dystrophy type of arRP. Only 2 
affected individuals in each sibship were sufficient to lead to mutation identification by 






Photoreceptor degenerations are the leading cause of inherited blindness1. This is partly 
explained by the extreme genetic heterogeneity of these conditions with 160 genes currently 
registered in the RetNet database (www.sph.uth.tmc.edu/retnet), reflecting the vast repertoire 
of genes necessary for photoreceptor function. Concurrently, there is a variety of phenotypes 
caused by photoreceptor loss, which are classified in many clinical entities depending on the 
presence or absence of systemic involvement, the severity and course of the disease, the 
location and shape of retinal lesions and deposits, the involvement of either rod, cone, or both 
photoreceptors, and the type of electrical responses to light stimuli. The most frequent clinical 
entity, non syndromic retinitis pigmentosa (RP), is also the most genetically heterogeneous, 
with 51 disease causing genes being currently known in this condition. From these, 32 cause 
autosomal recessive (ar) forms of the disease, accounting for 50 to 60 % of all arRP cases1. 
 
Molecular diagnosis in arRP thus requires the systematic sequencing of 506 exons to cover 
the 32 genes. This is a tremendous task with conventional sequencing methods, which in 
addition can miss mutations located in non coding regions. Exome sequencing using high 
throughput sequencing technologies are powerful new methods, but they still remain costly. 
Alternatively, homozygosity mapping in inbred, multiplex families or isolated cases, is time 
saving by readily pointing at only one or a few regions containing an already known disease 
causing gene or at new genes/loci2. This strategy has also been successful in a variable 
proportion of cases from outbred families which carry a homozygous mutation, due to 
inbreeding encountered in some populations2-4. However, homozygous regions unlinked to 
disease phenotypes are common in the human genome5, and therefore may erroneously 
suggest false candidate regions. In addition, the majority of families originating from 
countries with mixed populations are outbred and the affected patients carry compound 
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heterozygous mutations. For these families, homozygosity mapping will thus remain 
uninformative. 
 
Here, we devised a strategy based on gene mapping in non consanguineous families to search 
for mutations in known genes. In two families, we performed a genome wide SNP analysis 
and found many candidate chromosomal regions. By determination of a score from 
genotyping results and by assessment of phenotype features, we selected one candidate gene 
in each family. This process allowed to identify novel mutations in TULP1 and in the recently 
described C2ORF71, thus evidencing the potential interest of this method for mutation 
finding in small outbred families. 
 
METHODS 
Patients and clinical investigations 
Two non-consanguineous French families (RP127 and RP1459) with non syndromic RP and 
evidence of autosomal recessive inheritance were recruited (Figure 1A, C). In RP127, two out 
of six siblings were affected; parents and offsprings from the two affected patients were 
normal. In RP1459, two out of three sisters were affected; parents were normal. Informed 
consent and blood samples were obtained from family members. The investigators followed 
the tenets of the Declaration of Helsinki. 
 
Patients had standard ophthalmologic examination (refractometry, visual acuity, slit-lamp 
examination, applanation tonometry, funduscopy). Kinetic visual fields were determined with 
a Goldman perimeter with targets V4e, III4e and I4e. OCT measurement of the macula was 
performed using an OCT-3 system (Stratus model 3000, Carl Zeiss Meditec, CA) with the 
software version 3.0. Autofluorescence measurements were obtained with the HRA2 
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Heidelberg retinal confocal angiograph (Heidelberg Engineering, Dossenheim, Germany) and 
fundus pictures were taken. Full-fields ERG was recorded using a Ganzfeld apparatus 
(Metrovision, Pérenchies, France) with a bipolar contact lens electrode on maximally dilated 
pupils according to the ISCEV protocol6. 
 
Genotyping and mapping 
Genomic DNA was extracted from 10-ml peripheral blood samples by a standard salting out 
procedure7. Eleven members of the RP127 family and the 3 sisters of the RP1459 family were 
genotyped for 262,270 SNPs (GeneChip Mapping 250K Nsp Array, Affymetrix, Santa Clara, 
CA) at the Centre National de Génotypage (http://www.cng.fr), Evry, France or at 
DNAVision, Charleroi, Belgium. Results were analyzed using TASE (for transmitted allele 
search engine), a software designed in our laboratory (http://www.inmfrancetools.com/TASE) 
to search for common genotypes in all affected individuals (CGAA test). This test compares 
every SNP between each individual in the family, and assigns 1 of 3 possible states to each 
SNP: i) excluding SNP (affected individuals have different genotypes), ii) neutral SNP (all 
affected individuals share the same genotype with some non affected individuals) and iii) 
qualifying SNP (all affected individuals share the same genotype while non affected 
individuals carry another genotype). Candidate chromosomal regions were then defined as 
stretches of neutral and/or qualifying SNPs encompassing regions that were > 5 Mb and 
assigned centromeric and telomeric boundaries defined by 2 consecutive excluding SNPs. For 
each chromosome, the results were displayed as a chart showing the status of each SNP (see 
http://www.inmfrancetools.com/TASE), and the candidate regions were then compared to the 






Selection of candidate genes 
This was based on data issued from gene mapping and phenotype characterization. For a 
given candidate region, the probability to contain the causative gene usually increases with its 
coverage (average number of SNPs per megabase) and the qualifying rate (percentage of 
qualifying SNPs over the total number of SNPs in the region). We calculated a qualifying 
score defined as the product of coverage*qualifying rate/10 that took into account these two 
parameters. Regions with the highest qualifying scores were considered as those with the 
highest probability to contain the causative gene. In parallel, known retinal disease genes 
present in the candidate regions were listed, and the phenotypes usually caused by mutations 
in these genes were compared with the phenotype observed in the patients for each family. 
For each gene, the comparison was qualified as “concordant” when the candidate genes were 
indeed responsible for an arRP form similar to that observed in the families or as “non 
concordant” when candidate genes were responsible for RP (or non RP) phenotypes different 
from that observed in the family. Only a few occurrences of concordant phenotypes with the 




All exons and exon-intron boundaries of TULP1 (GenBank accession # NM_003322.3) and 
C2ORF71 (GeneBank accession # NM_001029883.1) were sequenced. Primer pairs chosen 
for the 15 TULP1 exons and the 2 C2ORF71 exons are available on request. Each PCR was 
performed in a 25-µl reaction mix containing 50 ng genomic DNA, 2 mM MgCl2, 200 µM 
dNTPs, 0.2 µM of each primers and 1U of Taq DNA Polymerase AmpliTaq Gold (Applied 
Biosystems, Foster City, CA) in its appropriate buffer. Following the first denaturation at 
95°C for 9 min, amplification was carried out for 35 cycles at 95°C for 30 s, at the melting 
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temperature (Tm) of the primers (56°C-60°C) for 1 min and at 72 °C for 1 min, ending with a 
final extension step at 72 °C for 10 min. PCR products were purified with ExoSap-it clean up 
(Amersham Biosciences, Piscataway, NJ) and sequenced using the BigDye Terminator cycle 
sequencing ready reaction kit V3.1 on an Applied Biosystems 3130xL genetic analyser (both 
Applied Biosystems, Forster city, CA) following manufacturer’s instructions. Sequencing 





Proband (II.5) had night blindness and visual field defects since early childhood. At time of 
presentation (age 42), she had moderate myopia (-1.25(-1.50;40°) OD; -1.00(-1.75;10°) OS). 
She was counting fingers on the right eye and had hand motion on the left eye. She had 
posterior subcapsular cataract and intraocular pressure was normal at 14 mmHg on both eyes. 
Her fundus showed a bilateral macular atrophy and dense bone spicule-shaped pigment 
deposits in retinal periphery (Figure 2A, B). Retinal vessels were highly attenuated and optic 
discs were pale. She was seen again at age 55 and had only light perception in both eyes. 
Visual field was undetectable. 
 
Her affected eldest brother (II.2) also had night blindness and visual field defects since early 
childhood, leading to the diagnosis of RP at age 5. He could never drive. Yet, he was able to 
read until the age of 33, at which time he had cataract surgery but no improvement in visual 
acuity. At 40, he was virtually blind and needed a white stick to move outside. At time of 
presentation (age 54) he had no light perception in the right eye and faint light perception in 
the left eye. Intraocular pressure was normal at 14 mmHg in both eyes. The macula had a 
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yellowish, disorganized aspect and many bone spicule-shaped pigment deposits were present 
in mid periphery (Figure 2C, D). Retinal vessels were hardly visible and he had waxy optic 
discs. He died from repeated cardiac infarctions. 
 
Mother (I.2), patients’ sibs (II.1, II.3, II.4, II.6) and patients’ children (III.1, III.2, III.3, III.4) 




Proband (II.2) had moderate dyschromatopsia since early childhood. Later on, at age 14 she 
noticed moderate night blindness and photophobia. She had difficulties to distinguish fine 
objects in far sight but had no reading difficulties. She did not complain of loss in the 
peripheral visual field and was able to drive her car in day time. At the time of presentation 
(age 25), her visual acuity was moderately decreased at 20/30 on both eyes with myopic 
refraction -6.75(-1.75;45°) OD; -5.75(-0.75;110°) OS. Intraocular pressure was normal at 14 
mmHg on both eyes. Lenses were transparent. Her fundus showed slightly discolored foveas 
with loss of foveal reflex, slightly pale optic discs and vascular attenuation (Figure 3A). There 
were no pigment deposits or retinal atrophy. Autofluorescence of macula was moderately 
heterogeneous whereas that of peripheral retina was normal (Figure 3B). OCT scans showed 
thinning of the retina with loss of the IS/OS line in both fovea and macula (Figure 3E). 
Goldman perimetry showed that peripheral isopter V4e was normal (90° temporal, 60° nasal) 
but there was a relative central scotoma on 20° around fixation at I4e in both eyes. Moderate 
tritanopia was confirmed on desaturated 15 HUE test. ERG testing showed barely detectable 
responses both in scotopic (responses only at maximal stimulation) and photopic conditions 
(responses only at 30-Hz flickers) (Figure 3G). 
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Affected sister (II.1) had moderate dyschromatopsia and night blindness since early 
childhood. At age 20 she noticed moderate photophobia. She had slight reading difficulties. 
She did not complain of loss in the peripheral visual field and was able to drive her car both in 
day and night time. At the time of presentation (age 30), her visual acuity was moderately 
decreased at 20/40 on both eyes with +1.50(-1.75;95°) OD; +1.50(-1.75;70°) OS. Lenses were 
transparent. Her fundus showed slightly discolored foveas with loss of foveal reflex, normal 
optic discs and moderate vascular attenuation (Figure 3C). There were no pigment deposits or 
retinal atrophy. Autofluorescence of macula was moderately heterogeneous whereas that of 
peripheral retina was normal (Figure 3D). OCT scans showed thinning of the retina with loss 
of the IS/OS line in the macula and relative sparing in the fovea (Figure 3F). Goldman 
perimetry showed that peripheral isopter V4e was moderately decreased (70° temporal, 50° 
nasal) with relative central scotoma on 20° around fixation at I4e in both eyes. There was non 
systematized dyschromatopsia confirmed on desaturated 15 HUE test. ERG testing showed 
barely detectable responses in photopic conditions but responses in scotopic conditions were 
still present even for the lowest stimuli, although attenuated (Figure 3G). 
 
The parents (II.1, II.2) and sister II.3 had no symptoms, normal visual acuity and funduscopy, 
indicating that they did not have RP. Yet, they all had slightly decreased photopic responses 
at ERG (Figure 3G). Based on dyschromatopsia, decreased visual acuity while peripheral 
visual field was normal, and ERG finding in II.1, we concluded that affected sisters II.1 and 
II.2 had the cone rod dystrophy form of arRP, with some intrafamilial variations. 
 




Genome wide SNP genotyping was performed on the 11 members of family RP127. Using 
the TASE software, we found that 33 chromosomal regions were common to the two affected 
patients, with an average length of 21 Mb (range: 5-68 Mb) and coverage of 75.5 SNPs/Mb 
(range: 0.6-133 SNPs/Mb) (Table 1). The qualifying rate (QR) and qualifying score (QS) 
were first calculated for the 6 members of the sibship (generation II). The 5 best QS (range: 
233.1-56.5) were found to correspond (from highest to lowest QS) to chromosomes 3, 18, 6, 
11 and 5. Adding healthy members of the family from generations I and III should decrease 
the probability that affected sibs had common genotypes with another member of the family 
only by chance. When the mother I.2 (generation I) and the 4 members of generation III were 
added (11 members), the value of the QS therefore dropped but highlighted the genotype 
specific to the affected individuals. The order of the 5 best QS (range 20.4-9.5) changed to the 
chromosome 11 region first (QS 20.4), followed by chromosome 6 (QS 14.1) and then 1, 3 
and 5. We then listed all possible genes and phenotypes for each chromosomal region and 
compared them with the phenotype of affected members of family RP127. Fifteen of the 33 
regions contained 31 candidate genes previously reported in inherited retinal diseases (Table 
1). When comparing phenotypes caused by these candidate genes with the severe non 
syndromic arRP of the two affected family members, it was found that RPE65, ABCA4, 
SNRNP200, RHO, PROM1, TULP1, IMPDH1, RGR, SPATA7, TTC8, CNGB1 and CA4 were 
concordant. Of these, only TULP1 was in the chromosomal regions with the 5 best QS. Since 
TULP1 was repeatedly reported in severe RP cases and was also the candidate gene of 
chromosome 6 region with the second highest QS, we sequenced all TULP1 coding exons and 
exon-intron boundaries in the 11 family members. We found two nucleotide changes, 
c.932G>A in exon 10 and c.1025G>A in exon 11, resulting in two novel amino acid 
substitutions, p.Arg311Gln and p.Arg342Gln, respectively (Figure 1B). These substitutions 
segregated with the RP phenotype (Figure 1A). Indeed, affected patients II.2 and II.5 carried 
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both mutations in trans whereas healthy individuals carried either only one mutation or wild-
type alleles. These changes were not found in 57 unrelated controls, indicating that they were 
likely to be disease causing mutations. 
 
Family RP1459 
To test whether this strategy would be efficient in a smaller sibship, we performed genome 
wide SNP genotyping on the 3 sisters of family RP1459. Using the TASE software, we found 
that 40 chromosomal regions were common to the two affected sisters, with an average length 
of 19 Mb (range: 5-87 Mb) and coverage of 78 SNPs/Mb (range: 1-129 SNPs/Mb) (Table 2). 
The 7 best QS (range: 461.7-369.7) were found to correspond (from highest to lowest QS) to 
regions of chromosomes 6, 5, 2, 1, 8, 6 and 2. Eight of the 40 chromosomal regions contained 
14 candidate genes previously reported in inherited retinal diseases. When comparing 
phenotypes caused by these candidate genes with the arRP of the two affected sisters, it was 
found that 4 genes, C2ORF71, ZNF513, PRCD and PDE6G were concordant. Of these, only 
C2ORF71 and ZNF513 were included in one of the 7 chromosomal regions with the best QS, 
namely the chromosome 2 region being the seventh in QS rank. Among these two genes, 
C2ORF71 had previously been described in cone rod dystrophies8-10, a phenotype 
corresponding closely to what was found in the two sisters of family RP1459. The exons of 
C2ORF71 were therefore sequenced in the 5 family members. We found two variants in exon 
1; an insertion, c.2327_2328insC, and a deletion, c.2328_2344del17, both resulting in 
frameshifts, p.Leu777PhefsX34 and p.Leu777AsnfsX28, respectively (Figure 1D). These 
variants segregated with the RP phenotype (Figure 1C). Indeed, the two affected sisters 
carried both variants in trans whereas healthy sister and parents carried only one variant. 





With the advent of clinical trials for inherited retinal dystrophies, it is required to identify the 
causative gene. Indeed, the molecular identification permits the diagnosis of the RP subtype, a 
better patient follow up and prediction of disease course. This will also be necessary for gene 
therapy. However, molecular diagnosis in arRP, the most genetically heterogeneous form of 
inherited retinal disease, currently requires the screening of 32 genes, a process which was 
never fully completed by any research group because it is time and money consuming. To 
circumvent this difficulty, various genetic tests have been developed based on use of 
microchips testing for known mutations (Asper Biotech, Tartu, Estonia), use of re-sequencing 
microchips11 or preferential sequencing of mutation hot spots12. Yet, these strategies miss 
unknown mutations and/or rare genes. Another possibility is to perform phenotype-genotype 
correlations to orient genetic testing towards one or a few genes. Although this could be very 
efficient in rare occasions in which a particular clinical feature is specific to a single gene, like 
para-arteriolar preservation of the retinal pigment epithelium in CRB1 mutations13, in most 
cases the RP phenotype simply belongs to a broad class of RP subtype, such as severe versus 
moderate, or rod-cone versus cone-rod dystrophy, all of which contain many genes to test. 
 
Homozygosity mapping proved to be a very efficient method for identification of mutations 
and gene discovery in small inbred RP families2,14 as well as in about one third of patients 
from outbred families who carry homozygous mutations3,4,14. However, there remains about 
two thirds of outbred families, being the most frequent in countries with highly mixed 
populations, in which affected patients carry compound heterozygous mutations. In these 
families, gene mapping could lead to the causative gene if there is a sufficient number of 
affected patients in the sibship, a rather rare occurrence today15. Therefore, gene mapping of 
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non consanguineous families is usually used to ascertain a locus previously identified by 
homozygosity mapping, and to increase the probability of finding mutations in a novel gene. 
 
We show in this study that combining gene mapping and phenotype-genotype correlation in 
small outbred families leads to the identification of the causative genes among several dozen 
of theoretically possible RP genes. Gene mapping is based on the assumption that the 
responsible gene must be present in chromosomal regions where affected patients from a 
single sibship have the same genotype. Although we found that in 260,000-SNP microchips 
many regions respond to this criterion, we could restrain the search to a few regions which 
had the highest qualifying scores (QSs). The QS varies for the one part with the SNP 
coverage of the chromosomal region, and for the other part with the density of qualifying 
SNPs in the region, herein called the qualifying rate (QR). Indeed, if the QR is low, this 
means that most SNPs of a given region have a genotype common to affected patients and to 
unaffected individuals of the kindred, making it unlikely to contain the causative gene. 
Conversely, if the QR is high, genotype of affected patients is different from that of 
unaffected individuals for many SNPs, therefore increasing the probability for the given 
region to contain the causative gene. With the increasing number of genes described in 
inherited retinal diseases, there are also an increasing number of precise phenotype 
descriptions16. Thus, there were only a limited number of genes that fulfilled the criteria of a 
high QS and phenotype concordance. Therefore, combining both approaches appears useful 
for rapid mutation identification. 
 
The tubby-like protein 1 (TULP1) contains 542 amino acids, among which the ~260 C-
terminal amino acids form the tubby domain conserved in Tubby and in the three TULP 
proteins (Figure 4A). TULP1 is specific to photoreceptor cells and is expressed in the inner 
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segment, connecting cilium and synapses of photoreceptors. Today, 24 pathogenic variants 
have been described in TULP1, including 12 missense and 12 nonsense or frameshift 
mutations 17-27. Ten out of the 12 missense mutations are present in the tubby domain. The 
two novel missense mutations R311Q and R342Q that we have found in this study also affect 
amino acids of the tubby domain. Using a protein data bank software 
(http://www.rcsb.org/pdb), we predict that Q311 would no longer be able to interact with 
F535 as does wild type R311 do, therefore possibly destabilizing the protein. We also 
speculate that Q342, in contrast to wild type R342, could increase the flexibility of the 
external loop of TULP1, therefore preventing protein-protein interactions. The early onset 
severe RP observed in the two patients carrying these mutations was in accordance with the 
phenotype described in TULP1 patients. Thus, R311Q and R342Q are likely pathogenic 
changes. 
 
C2ORF71 encodes a 1288-amino acid protein with no known homology. The mRNA was 
shown to be specifically expressed in photoreceptors8,9. In these cells, C2ORF71 could 
possibly be associated with the photoreceptor connecting cilium and also play a role in the 
photoreceptor development since it associates with basal bodies of the developing cilium9. 
Using homozygosity mapping of consanguineous families, five pathogenic variants were 
recently reported in this gene8,9, four of them being nonsense or frameshift mutations. A 
medium scale systematic screening in 191 arRP and 95 Leber congenital amaurosis patients 
did not find any mutation, suggesting that C2ORF71 is not a frequent gene of inherited retinal 
dystrophies10. The two novel variants found in this study are also frameshift mutations in 
compound heterozygous patients, unambiguously indicating that they are pathogenic. Among 
the five previously reported families, one Dutch family was described in more details, 
featuring criteria of cone rod dystrophy based on worse cone ERG responses when compared 
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to rod ERG responses. This corresponds well to patient II.1 from this study, showing that 
phenotype genotype correlation was relevant and, together with gene mapping, led to efficient 
mutation finding. 
 
In conclusion, a combined approach of gene mapping and phenotypic assessment was 
efficient to find, among many possible chromosomal regions and causative genes, the 
mutations in two non consanguineous families. 
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TITLES AND LEGENDS TO FIGURES 
 
Figure 1: Pedigrees and sequence analysis in 2 families segregating autosomal recessive 
retinitis pigmentosa. A, C: pedigree of families RP127 (A) and RP1459 (C); blackened 
symbols are affected individuals, mutation genotypes for TULP1 (A) or C2ORF71 (C) is 
indicated under each family member (“+” means a wild-type allele). B, D: electropherograms; 
the normal sequence is written in black italic and the mutated nucleotides are in red. B, 
TULP1 sequence for each of the two mutations in patient (indicated above) compared to wild 
type (normal) is shown. D, C2ORF71 sequence for each of the two mutations in either father 
or mother (indicated above) is shown and compared to that of patient who carry both 
mutations in exon 1 and of wild type individual (normal). 
 
Figure 2: Fundus images of affected patients in family RP127. A, right and B, left eye 
posterior poles of patient II.5 at age 42 showing round shape atrophy of the macula, advanced 
atrophy of the peripheral retina, pigment deposits and narrowing of retinal vessels. C, superior 
and D, inferior retina in the right eye of patient II.2 at age 54 showing major atrophy of the 
whole retina including retinal periphery and macula, with pigment deposits, tenuous retinal 
vessels and waxy pale optic discs. 
 
Figure 3: Clinical findings in family RP1459. A, C, fundus photographs and B, D, fundus 
autofluorescence of left eye of patients II.2 (A, B) and II.1 (C, D) showing slight discoloration 
of fovea, loss of normal foveal reflex and moderate narrowing of retinal vessels (A, C) and 
alteration of the foveal retinal pigment epithelium (B, D). E, F, OCT scans of left eye of 
patients II.2 (E) and II.1 (F) showing thinning of the retina with relative preservation of foveal 
photoreceptors. G, electroretinogram recordings showing the dramatic reduction of light-
19 
 
adapted responses of patients II.1 and II.2 with relatively conserved dark-adapted response of 
patient II.1, compared to normal responses in a control individual (normal) and to slightly 




Table 1: data analysis for family RP127 
Chrom Length Coverage 
6 members 11 members 
Genes 
  Concordance with 
phenotype of 
affected patients QR QS QR QS Disease 
1 7 52 4,87 25,3 2,5 13,0     
1 51 95 0,12 1,1 0 0,0 RPE65 LCA, RP Concordant 
        ABCA4 MD, CRD, RP Concordant 
        COL11A1 Stickler Non concordant 
        GNAT2 Achromatopsia Non concordant 
1 24 1 11,11 1,1 0 0,0     
2 12 102 0,08 0,8 0 0,0     
2 18 110 2,5 27,5 0 0,0 EFEMP1 MCDR Non concordant 
2 5 0 0 0,0 0 0,0 SNRNP200 RP Concordant 
3 26 93 1,2 11,2 0,12 1,1     
3 5 113 20,63 233,1 0,88 9,9     
3 60 84 0,05 0,4 0,02 0,2 IQCB1 SLS Non concordant 
        RHO RP Concordant 
        NPHP3 SLS Non concordant 
        CLRN1 USH Non concordant 
4 9 120 1,8 21,6 0 0,0 PROM1 RP, MCDR Concordant 
5 16 90 6,28 56,5 0,71 6,4     
5 27 98 3,21 31,5 0,97 9,5     
6 32 99 8,12 80,4 1,42 14,1 TULP1 LCA, RP Concordant
6 20 106 0,09 1,0 0,09 1,0     
7 51 78 0,07 0,5 0 0,0 TSPAN12 FEVR Non concordant 
        IMPDH1 RP Concordant 
        OPN1SW Tritanopia Non concordant 
8 6 18 0 0,0 0 0,0     
9 29 0 0 0,0 0 0,0     
10 5 126 0,15 1,9 0,16 2,0     
10 68 96 3,9 37,4 0,37 3,6 CDH23 USH Non concordant 
        CDHR1 CRD Non concordant 
        RGR RP Concordant 
        PDE6C CD Non concordant 
        RBP4 RPE dystrophy Non concordant 
        PAX2 Coloboma Non concordant 
11 21 117 0,16 1,9 0 0,0 USH1C USH Non concordant 
11 18 63 0,26 1,6 0,18 1,1     
11 14 88 7,32 64,4 2,32 20,4 MYO7A USH Non concordant 
11 14 88 0,24 2,1 0,08 0,7 C1QTNF5 MCDR Non concordant 
14 19 77 2,99 23,0 0,41 3,2 SPATA7 LCA, RP Concordant 
        TTC8 BBS, RP Concordant 
16 6 0 0 0,0 0 0,0     
16 9 97 5,79 56,2 0,22 2,1 RPGRIP1L JBTS Non concordant 
        BBS2 BBS Non concordant 
        CNGB1 RP Concordant 
17 16 50 0 0,0 0 0,0 UNC119 CRD Non concordant 
17 22 58 0 0,0 0 0,0 CA4 RP Concordant 
18 35 91 17,08 155,4 0,64 5,8     
18 11 133 0,13 1,7 0 0,0     
19 8 1 0 0,0 0 0,0     
21 14 93 5,78 53,8 0,3 2,8     
22 5 47 3,36 15,8 0 0,0       
Length is in Mb; coverage is the average number of SNPs/Mb; QR: qualifying rate is the 
percentage of qualifying SNPs/total number of SNPs; QS: qualifying score is the product of 
coverage*QR/10; BBS: Bardet Biedl syndrome; CD: cone dystrophy; CRD: cone rod 
dystrophy; FEVR: familial exudative vitreoretinopathy; LCA: Leber congenital amaurosis; 
MD: macular dystrophy; RP: retinitis pigmentosa; SLS: senior loken syndrome 
Table 2: data analysis for family RP1459 





1 12 118 34.97 412.6     
1 24 2 11.26 2.2     
1 16 89 38.93 346.4 SDCCAG8 Nephronophtisis Non concordant 
2 25 98 37.73 369.7 C2ORF71 RP, CRD Concordant 
     ZNF513 RP Concordant 
2 8 90 25.79 232.1     
2 7 4 26.47 10.5     
2 6 95 0 0     
2 14 88 24.08 211.9     
2 9 106 39.54 419.1     
3 5 6 15.62 9.3     
4 6 116 28.98 336.1     
4 21 101 35.18 355.3     
4 44 91 3.33 30.3     
5 5 22 2.72 5.9     
5 10 84 39.42 331.1 VCAN Wagner Non concordant 
5 7 128 34.29 438.9     
6 11 101 29.95 302.5     
6 48 95 40.58 385.5 ELOVL4 MD Non concordant 
6 7 114 40.5 461.7     
7 13 129 25.97 335     
7 6 69 27.64 190.7     
8 5 105 21.17 222.2     
8 6 15 0 0     
8 31 101 39.96 403.5    
9 31 1 34.21 3.42     
10 40 92 13.06 120.1     
10 18 90 23.14 208.2 CDH23 Usher syndrome Non concordant 
10 16 99 35.73 353.7 OAT Gyrate atrophy Non concordant 
11 17 99 6.74 66.7     
12 87 96 33.02 316.9 BBS10 BBS Non concordant 
     CEP290 LCA, SLS, JS Non concordant 
     COL2A1 Sticker, Wagner Non concordant 
     RDH5 FA, CD Non concordant 
12 20 75 3.58 26.8     
13 11 114 32.4 369.3     
15 20 95 0.26 2.47     
16 11 106 28.4 301     
16 13 5 11.94 5.9     









18 32 89 27.6 245.6     
18 10 119 6.85 81.5     
19 9 12 24.32 29.1     
19 8 55 2.02 11.1       
Length is in Mb; coverage is the average number of SNPs/Mb; QR: qualifying rate is the 
percentage of qualifying SNPs/total number of SNPs; QS: qualifying score is the product of 
coverage*QR/10; BBS: Bardet Biedl syndrome; CD: cone dystrophy; CRD: cone rod 
dystrophy; FA: fundus albipunctatus; JS: Joubert syndrome; LCA: Leber congenital 
amaurosis; MD: macular dystrophy; RP: retinitis pigmentosa; SLS: senior loken syndrome; 
Stickler: Stickler syndrome; Wagner: Wagner disease 
